Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7380 p735
17 December 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Society criticised despite winning High Court appeal

Manchester pharmacist Allan Stuart Black was rightly struck off by the Royal Pharmaceutical Society's Statutory Committee earlier this year, a High Court judge has ruled (PJ, 16 April, p468). However, the judge criticised the Society for treating him unfairly despite dismissing Mr Black's appeal.

Mr Black, who was superintendent pharmacist of Formans (Chemists) Ltd, over-claimed £52,000 from the Prescription Pricing Authority after getting in a muddle when his marriage broke down. Formans has fully repaid the over-payment. Mr Black was never accused of dishonesty, but Mr Justice Collins said that his conduct remained too serious to be dealt with by only a reprimand despite unfairness in the way he had been dealt with by the Society.

The mother of the patient who was prescribed the drug was to have given evidence in Mr Black’s support at a Statutory Committee hearing in January. But she had told the Society by fax two days before the hearing that she could not attend. Mr Black and his legal team were not informed she could not attend until the day of the hearing.

Mr Justice Collins observed: “The manner in which the respondent (the Society) dealt with the problem caused by Mrs J’s inability to attend merits severe criticism.”

The judge said that the absence of dishonesty on Mr Black’s part, his previously flawless reputation and the fact that his error did not put any patient at risk would normally have made suspension from the Register, rather than erasure, the appropriate sanction. However, the judge said that the Society had no power to suspend pharmacists.

The judge said: “Serious though his misconduct was, I think that he should be given the opportunity to seek reinstatement before the usual three-year period has elapsed. I would recommend that favourable consideration should be given to an application for reinstatement made once 12 months have elapsed.”

Mandie Lavin, the Society’s director of fitness to practise and legal affairs, said: “We are pleased the judge has upheld the decision to remove the appellant from the Register. We are also pleased the judge has recognised the current limitations to our legislation and we have been working hard to formulate legislation to enable us to discharge our duties as a modern regulator. We will be reviewing our arrangements for summoning witnesses in the light of the judge’s comments. We are currently reviewing all our procedures in preparation for our new Section 60 requirements.”

Back to Top


©The Pharmaceutical Journal